An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial.
Publication
, Journal Article
Gurbel, PA; Tantry, US
Published in: JAMA
March 16, 2011
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 16, 2011
Volume
305
Issue
11
Start / End Page
1136 / 1137
Location
United States
Related Subject Headings
- Ticlopidine
- Thrombosis
- Risk
- Randomized Controlled Trials as Topic
- Precision Medicine
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Platelet Activation
- Myocardial Infarction
Citation
APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., & Tantry, U. S. (2011). An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial. JAMA, 305(11), 1136–1137. https://doi.org/10.1001/jama.2011.332
Gurbel, Paul A., and Udaya S. Tantry. “An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial.” JAMA 305, no. 11 (March 16, 2011): 1136–37. https://doi.org/10.1001/jama.2011.332.
Gurbel PA, Tantry US. An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial. JAMA. 2011 Mar 16;305(11):1136–7.
Gurbel, Paul A., and Udaya S. Tantry. “An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial.” JAMA, vol. 305, no. 11, Mar. 2011, pp. 1136–37. Pubmed, doi:10.1001/jama.2011.332.
Gurbel PA, Tantry US. An initial experiment with personalized antiplatelet therapy: the GRAVITAS trial. JAMA. 2011 Mar 16;305(11):1136–1137.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 16, 2011
Volume
305
Issue
11
Start / End Page
1136 / 1137
Location
United States
Related Subject Headings
- Ticlopidine
- Thrombosis
- Risk
- Randomized Controlled Trials as Topic
- Precision Medicine
- Platelet Function Tests
- Platelet Aggregation Inhibitors
- Platelet Aggregation
- Platelet Activation
- Myocardial Infarction